45
https://pubmed.ncbi.nlm.nih.gov/38092962
The abstract reports a study finding that phytohemagglutinin-activated CAR-T cells exhibit enhanced stability, persistence, and efficacy in a CD19+B-cell cancer model, offering a promising strategy for improving cancer immunotherapy.
